Clin Mol Hepatol.
2025 Apr;31(2):584-588. 10.3350/cmh.2024.0945.
A novel clinical trial for primary sclerosing cholangitis from Asia: All regional endeavors should improve global management of primary sclerosing cholangitis: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
- Komori A
1,2
- Affiliations
-
- 1Clinical Research Center, NHO Nagasaki Medical Center, Omura, Nagasaki, Japan
- 2Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Omura, Nagasaki, Japan
- KMID: 2566979
- DOI: http://doi.org/10.3350/cmh.2024.0945
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Challenges and innovations in primary sclerosing cholangitis clinical trials: Evaluating HK-660S and the path forward: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
- Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
- Biliary Tract & Pancreas; A Case of Cholangiocarcinoma Suggested as Developing in the Patient with Primary Sclerosing Cholangitis
- Primary Sclerosing Cholangitis in Patients with Ulcerative Colitis: Two Case Reports
- Primary Sclerosing Cholangitis: One Case Report
